Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07544732

Effects of Low-Dye Taping Compared to Calcaneal Taping in Patients With Plantar Fasciitis

Plantar fasciitis is a common musculoskeletal condition characterized by inflammation and microtears of the plantar fascia, leading to heel pain, particularly during initial steps after rest. It negatively impacts gait, mobility, and overall quality of life. Physiotherapy interventions such as stretching, strengthening, electrotherapy, and taping techniques are commonly used for management. Among these, Low-Dye taping and calcaneal taping provide biomechanical support by reducing strain on the plantar fascia and improving foot posture; however, comparative evidence between the two is limited.

This study aims to evaluate the effectiveness of Low-Dye taping versus calcaneal taping in reducing pain and improving foot function in patients with plantar fasciitis. A total of 36 participants will be randomly assigned to either intervention group and treated over a two-week period. Outcome measures will include pain (VAS), functional ability (FFI), ankle range of motion (goniometer), and gait analysis, assessed before and after intervention. Data will be analyzed using SPSS v27, with statistical significance set at p < 0.05.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Plantar Fascia

Age range

19 year–44 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

Plantar fasciitis is a common musculoskeletal condition characterized by inflammation and micro tears of the plantar fascia, often resulting in sharp heel pain during the first steps in the morning or after prolonged rest. It significantly affects gait, functional mobility, and quality of life. Conservative physiotherapy interventions such as stretching, strengthening, and electrotherapy are widely used. Taping techniques like Low-Dye and Calcaneal taping offer biomechanical support by reducing strain on the plantar fascia, improving foot posture, and alleviating symptoms. Despite the frequent use of both techniques, there is a lack of direct comparative evidence to guide best practice. The objective of this research study is to compare the effectiveness of low dye taping and calcaneal taping in reducing pain and improving foot function in patients with plantar fasciitis. 36 Participants clinically diagnosed with plantar fasciitis will be randomly allocated to either the LDT (low dye taping) groupor theCT (calcaneal taping) group. The intervention will be administered over a fixed period.

Outcome measures will include the Visual Analog Scale (VAS) for pain, Foot Function Index (FFI) for functional limitation, goniometer for ankle rangeof motion and observational gait analysis recorded before and after the intervention. A total of 36 participants will be divided into two groups, group A (LDT) and group B (CT), according to the inclusion criteria such as clinical diagnosis of plantar fasciitis, age range, and absence of other foot or systemic pathologies.

Informed consent will be obtained. Baseline data, including VAS, FFI scores, goniometric measurements and gait analysis will be recorded, each participant will receive taping for 2 weeks. Post-intervention scores will be collected. Data will be analyzed using SPSS v27. Descriptive statistically will summarize demographics.

Inferential statistics (paired-t- test /independent t test) will compare pre- and post-treatment changes within and between groups with significance of p <0.05.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults of 19 - 44 years old age.
  • Both genders will be included
  • Pain in plantar heel lasting more than three months
  • Clinical diagnosis of unilateral PF in compliance with the American
  • physical therapy association's (APTA) Orthopedic Section clinical practice
  • guidelines
  • Positive windlass test
  • Negative tarsal tunnel tests
  • Limited active and passive talocrural joint dorsiflexion range of motion
  • Pain on the inner side of the heel is most noticeable with the first steps after
  • rest and tends to worsen after standing or walking for a long time.
  • Willing and capable of adhering to the study procedure and completing follow-up
  • examinations.
  • Planter fascia tests i.e. windlass mechanism, hop test, stair climbing.
  • Sedentary individuals (no exercise plan followed in last 3 months)

Exclusion criteria

  • • Previous surgical intervention for plantar fasciitis.
  • Congenital abnormalities of foot.
  • Lower extremities affected by systemic disorders, such as rheumatoid arthritis,
  • diabetes or peripheral neuropathy.
  • The presence of additional foot disorders, such as stress fractures, Achilles
  • tendinopathy, or nerve entrapment syndromes.
  • Any contraindications to taping, such as skin sensitivity or allergy.
  • Not willing or not capable of adhering to the study procedure and completing follow-
  • up examinations.
  • Pregnant women, mental illness, immune suppressed patients, patients with
  • peripheral vascular disease, thrombocytopenia patients, anti-coagulant therapy
  • patients and post mastectomy.

Treatment and study plan

Low Dye Taping

Procedure
  • Taping through standard protocol
  • Conventional physical therapy
  • Calf and fascia stretch
  • Ultrasound therapy Duration: 2 weeks Frequency: 3 sessions per week (Total = 6 sessions) Mode: Continuous mode for chronic symptoms Frequency (Hz): 1 MHz (for deep tissues like plantar fascia) Intensity: 1.0 - 1.5 W/cm² (start with 1.0 and progress based on tolerance) Treatment time: 5-8 minutes per session Applicator size: Small (2-5 cm² sound head)

Technique:

  • Apply coupling gel to the heel and medial arch area.
  • Move the applicator slowly in circular motion over the plantar fascia.
  • Cover the entire tender area, especially the medial calcaneal tubercle
  • Strengthening exercises

Calcaneal Taping

Procedure
  • Taping through standard protocol
  • Conventional physical therapy
  • Calf and fascia stretch
  • Ultrasound therapy Duration: 2 weeks Frequency: 3 sessions per week (Total = 6 sessions) Mode: Continuous mode for chronic symptoms Frequency (Hz): 1 MHz (for deep tissues like plantar fascia) Intensity: 1.0 - 1.5 W/cm² (start with 1.0 and progress based on tolerance) Treatment time: 5-8 minutes per session Applicator size: Small (2-5 cm² sound head)

Technique:

  • Apply coupling gel to the heel and medial arch area.
  • Move the applicator slowly in circular motion over the plantar fascia.
  • Cover the entire tender area, especially the medial calcaneal tubercle
  • Strengthening exercises

Primary outcomes

  1. Pain Intensity

    Time frame: groups will be assessed at baseline and 2 weeks to evaluate treatment outcomes.

    The Visual Analogue Scale (VAS) is used to measure pain. The tool comprises of a straight line, either horizontal or vertical, typically measuring 10 cm (or an acceptable length). It is marked with labels at each end that indicate the extreme values of the parameter being assessed, such as "no pain" and "worst possible pain" for evaluating pain intensity. The distance between the initial position and the mark made by the respondent is quantified and employed as a quantitative measure, usually falling within the range of 0 to 100. Higher 9 scores signify a higher level of intensity or severity.

  2. Foot Functional Index

    Time frame: groups will be assessed at baseline and 2 weeks to evaluate treatment outcomes.

    The Foot Function Index (FFI) questionnaire is a commonly used outcome measure tool for evaluating foot function and discomfort in persons with diverse foot problems, such as plantar fasciitis. The assessment is composed of three subscales: pain, disability, and activity limitation. Each subscale includes several items that are assessed on a Likert scale. The Foot Function Index (FFI) quantifies the influence of foot-related issues on everyday tasks, including walking, standing, and engaging in leisure activities. Scoring interpretation entails adding together the scores of individual items inside each subscale to calculate subscale scores. Higher scores indicate more significant foot dysfunction and discomfort

  3. Range of Motion of foot

    Time frame: groups will be assessed at baseline and 2 weeks to evaluate treatment outcomes.

    Goniometer will be used to measure Ranges of Motion (ROM). It generally comprises of two arms, one stationary and one adjustable, equipped with a protractor-like scale for the measurement of angles. The immobile arm is positioned in line with the bone closest to the joint, while the mobile arm is positioned in line with the bone farthest from the joint. By accurately aligning the goniometer and carefully studying the joint's motion, a precise measurement of the joint angle is acquired

  4. Step Length

    Time frame: groups will be assessed at baseline and 2 weeks to evaluate treatment outcomes

    Step length will be assessed using observational gait analysis (OGA) through visual inspection and simple distance measurement. Unit of measurement is centimetres (cm)

  5. Stride Length

    Time frame: Baseline and 2 weeks

    Stride length will be assessed using observational gait analysis (OGA) through visual inspection and simple distance measurement.Unit of Measure is centimetres (cm)

  6. Cadence

    Time frame: Baseline and 2 weeks

    Cadence will be assessed using observational gait analysis (OGA) using stopwatch timing. Unit of Measure is steps per minute (steps/min)

  7. Walking Speed

    Time frame: Baseline and 2 weeks

    Walking speed will be assessed using observational gait analysis (OGA) by measuring time taken to cover a fixed distance.Unit of Measure is meters per second (m/s)

  8. Gait Cycle Time

    Time frame: Baseline and 2 weeks

    Gait cycle time will be assessed using observational gait analysis (OGA) with stopwatch timing. Unit of Measure is seconds (s)

Study contacts

Contact information is provided by the study sponsor or research team.

Anam Rehman, MS-OMPT

CONTACT

[email protected]

+923355082299

Areej Mazhar, DPT

CONTACT

[email protected]

03185337558

Sponsors and collaborators

Lead sponsor

Foundation University Islamabad

Other

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Apr 22, 2026
Registry last updated
May 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.